Further, aggressive invasive serous tumours, which are more frequently diagnosed at a later stage and more frequently elevate CA125 levels than other invasive tumour types,10 accounted for half of invasive tumours in women with abnormal CA125 test results and only a third of invasive cancers in women with normal CA125 test results. This evidence concerns the gene MUC16 and neoplasm.